Volume 379, Issue 9830, Pages (May 2012)

Slides:



Advertisements
Similar presentations
Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)
Advertisements

Volume 373, Issue 9659, Pages (January 2009)
Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker  Kyaw M Tun, MD, Dr Mallika Imwong,
Pharmacogenetics and future drug development and delivery
Spread of a single multidrug resistant malaria parasite lineage (PfPailin) to Vietnam  Mallika Imwong, Tran T Hien, Nguyen T Thuy-Nhien, Arjen M Dondorp,
Role of mass drug administration in elimination of Plasmodium falciparum malaria: a consensus modelling study  Oliver J Brady, DPhil, Hannah C Slater,
Table 1 Characteristics of patients at enrollment who received artesunate-amodiaquine (ASAQ) or artemether-lumefantrine (AL) for treatment of malaria.
The geography of imported malaria to non-endemic countries: a meta-analysis of nationally reported statistics  Prof Andrew J Tatem, PhD, Peng Jia, PhD,
Volume 383, Issue 9930, Pages (May 2014)
Total and cause-specific mortality before and after the onset of the Greek economic crisis: an interrupted time-series analysis  Ioannis Laliotis, PhD,
Volume 369, Issue 9563, Pages (March 2007)
Germany must invest in its global health academic workforce
Volume 5, Issue 4, Pages (April 2006)
Volume 13, Issue 3, Pages (March 2012)
New global estimates of malaria deaths
Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial 
Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax.
Characteristics and survival of patients with Ebola virus infection, malaria, or both in Sierra Leone: a retrospective cohort study  Matthew Waxman, MD,
Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment in early pregnancy: a population-based study  Dr R McGready,
Volume 375, Issue 9732, Pages (June 2010)
Mannose-binding lectin deficiency and disease severity in non-cystic fibrosis bronchiectasis: a prospective study  Dr James D Chalmers, MBChB, Brian J.
How to Contain Artemisinin- and Multidrug-Resistant Falciparum Malaria
Safety of artemisinins in first trimester of prospectively followed pregnancies: an observational study  Kerryn A Moore, MSc, Julie A Simpson, PhD, Moo.
The persistence and oscillations of submicroscopic Plasmodium falciparum and Plasmodium vivax infections over time in Vietnam: an open cohort study  Thuy-Nhien.
Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infection 
Spread of a single multidrug resistant malaria parasite lineage (PfPailin) to Vietnam  Mallika Imwong, Tran T Hien, Nguyen T Thuy-Nhien, Arjen M Dondorp,
Nicholas D Walter, Randall Reves, J Lucian Davis 
Effect of 3 years of biannual mass drug administration with albendazole on lymphatic filariasis and soil-transmitted helminth infections: a community-based.
AQ-13, an investigational antimalarial, versus artemether plus lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria: a randomised,
Volume 373, Issue 9682, Pages (June 2009)
Volume 391, Issue 10133, Pages (May 2018)
Safety of artemisinins in first trimester of prospectively followed pregnancies: an observational study  Kerryn A Moore, MSc, Julie A Simpson, PhD, Moo.
An update on Zika virus infection
Optimum population-level use of artemisinin combination therapies: a modelling study  Tran Dang Nguyen, BSc, Piero Olliaro, Prof Arjen M Dondorp, MD, Prof.
Marshall Burke, PhD, Sam Heft-Neal, PhD, Dr Eran Bendavid, MD 
Volume 376, Issue 9753, Pages (November 2010)
Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta- analysis  Prof Ric N Price, MD, Lorenz von Seidlein, PhD, Neena.
Effect of air quality alerts on human health: a regression discontinuity analysis in Toronto, Canada  Hong Chen, PhD, Qiongsi Li, MMath, Jay S Kaufman,
Volume 4, Issue 6, Pages (June 2017)
A voracious creature The Lancet Volume 358, (December 2001)
Origins of the current outbreak of multidrug-resistant malaria in southeast Asia: a retrospective genetic study  Roberto Amato, PhD, Richard D Pearson,
Role of mass drug administration in elimination of Plasmodium falciparum malaria: a consensus modelling study  Oliver J Brady, DPhil, Hannah C Slater,
Volume 393, Issue 10171, Pages (February 2019)
Volume 372, Issue 9649, Pages (November 2008)
Volume 386, Issue 10011, Pages (December 2015)
Risk of Plasmodium vivax parasitaemia after Plasmodium falciparum infection: a systematic review and meta-analysis  Robert J Commons, FRACP, Prof Julie.
Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker  Kyaw M Tun, MD, Dr Mallika Imwong,
The geography of imported malaria to non-endemic countries: a meta-analysis of nationally reported statistics  Prof Andrew J Tatem, PhD, Peng Jia, PhD,
Volume 2, Issue 6, Pages e243-e251 (June 2015)
Genetic markers associated with dihydroartemisinin–piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype–phenotype association.
Whole-genome sequencing to determine transmission of Neisseria gonorrhoeae: an observational study  Dilrini De Silva, PhD, Joanna Peters, MBBS, Kevin.
Volume 393, Issue 10172, Pages (February 2019)
Volume 393, Issue 10172, Pages (February 2019)
Volume 378, Issue 9787, Pages (July 2011)
The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual.
Low-technology approaches
Suppression of malaria vector densities and human infection prevalence associated with scale-up of mosquito-proofed housing in Dar es Salaam, Tanzania:
Long-term circulation of Zika virus in Thailand: an observational study  Kriangsak Ruchusatsawat, PhD, Pattara Wongjaroen, MSc, Arisara Posanacharoen,
Genital herpes—how much of a public-health problem?
The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: a molecular epidemiology observational study  Dr Mallika Imwong,
Volume 393, Issue 10177, Pages (March 2019)
Volume 372, Issue 9632, Pages (July 2008)
Stem cell transplantation
Volume 378, Issue 9799, Pages (October 2011)
Sputum culture conversion in new TB regimens
Environmental risk factors and exposure to the zoonotic malaria parasite Plasmodium knowlesi across northern Sabah, Malaysia: a population-based cross-sectional.
Volume 383, Issue 9930, Pages (May 2014)
The Lancet Infectious Diseases
Volume 379, Issue 9835, Pages (June 2012)
Global burden of latent multidrug-resistant tuberculosis: trends and estimates based on mathematical modelling  Gwenan M Knight, PhD, C Finn McQuaid,
Presentation transcript:

Volume 379, Issue 9830, Pages 1960-1966 (May 2012) Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study  Aung Pyae Phyo, MD, Standwell Nkhoma, PhD, Kasia Stepniewska, PhD, Elizabeth A Ashley, MD, Shalini Nair, MSc, Rose McGready, MD, Carit ler Moo, Salma Al-Saai, MSc, Arjen M Dondorp, MD, Khin Maung Lwin, MD, Pratap Singhasivanon, MD, Nicholas PJ Day, FRCP, Nicholas J White, FRS, Tim JC Anderson, PhD, Prof François Nosten, MD  The Lancet  Volume 379, Issue 9830, Pages 1960-1966 (May 2012) DOI: 10.1016/S0140-6736(12)60484-X Copyright © 2012 Elsevier Ltd Terms and Conditions

Figure 1 Parasite clearance half-life of Plasmodium falciparum on the Thailand–Myanmar border over 10 years We plotted untransformed parasite clearance half-lives over time for all malaria infections with a good fit to a linear model (R2>0.8). Data from western Cambodia gathered between June, 2007, and November, 2010, are shown for comparison, compressed as if they had been obtained in a single year. The dotted red line shows a threshold value of 6·2 h, used to differentiate between fast-clearing and slow-clearing infections. The dotted blue boxes show the periods for which bloodspots were available. These two time windows form the basis of the genetic analysis. The Lancet 2012 379, 1960-1966DOI: (10.1016/S0140-6736(12)60484-X) Copyright © 2012 Elsevier Ltd Terms and Conditions

Figure 2 Change in parasite clearance half-life of Plasmodium falciparum 2001–10 (A) Geometric means of parasite clearance half-life in patients with hyperparasitaemia on the Thailand–Myanmar border. *Subset of infections treated with artesunate monotherapy (ART) for more than 48 h, for which 48 h clearance rates and parasite clearance half-lives were calculated. Error bars are 95% CIs and above them is the number of patients. (B) Proportion of patients with very slow clearance (parasite clearance half-life≥6·2 h). Error bars are binomial 95% CIs. Colour scheme is as per A. The Lancet 2012 379, 1960-1966DOI: (10.1016/S0140-6736(12)60484-X) Copyright © 2012 Elsevier Ltd Terms and Conditions

Figure 3 Effect of parasite genotype on parasite clearance rates Clearance half-lives in patients infected with parasites bearing identical 93-locus genotypes. Red dotted line marks the 6·2 h threshold used to categorise slow-clearing parasites. The arrows show slow clearance parasite genotypes gathered in November, 2003. *Ranked by mean parasite clearance half-life. The Lancet 2012 379, 1960-1966DOI: (10.1016/S0140-6736(12)60484-X) Copyright © 2012 Elsevier Ltd Terms and Conditions